Prostate Cancer
New prostate cancer study findings have been reported by A. Dubrovska and colleagues
Published in Cancer Weekly, March 10th, 2009
"Characterization of the molecular pathways that are required for the viability and maintenance of self-renewing tumor-initiating cells may ultimately lead to improved therapies for cancer. In this study, we show that a CD133(+)/CD44(+) population of cells enriched in prostate cancer progenitors (PCaPs) has tumor-initiating potential and that these progenitors can be expanded under nonadherent, serum-free, sphere-forming conditions," scientists in the United States report.
"Cells grown under these conditions have increased in vitro clonogenic and in vivo tumorigenic potential. mRNA expression analysis of cells grown under sphere-forming conditions, compared with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-03-10)
More Articles from Cancer Weekly
- Johns Hopkins Medical Institutions
Prostate specific antigen testing may be unnecessary for some older men - Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals Reports Fourth Quarter and 2008 Financial Results - Breast Cancer
Landmark Report: Many Cancers Could be Prevented - Breast Cancer
New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy - Cancer
Landmark Policy Report: Many Cancers Could Be Prevented Across the Globe - Cancer
Report: Many Cancers Could Be Prevented in US - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
